Jobs / United States / Gilead Sciences INC
Clinical Data Scientist -RWE Data Analysis Oversight Lead: Inflammation
Gilead Sciences INC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles1 certified filing for “Associate Director, Data Scientist” (Data Scientists) in AZ: $195k–$195k, median $195k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description We are seeking a Clinical Data Scientist -RWE Data Analysis Oversight Lead: Inflammation. This position is responsible for the oversight of timeliness and quality of analysis results supporting the CDS-RWE book of work for the Inflammation therapeutic area (TA). This role reports to the CDS-RWE TA Head and supports the scientific leads in implementing strategies to generate analysis results that deliver on portfolio priorities. Serving as the primary point of contact for study and analysis vendors and service vendors, this role is responsible for planning, execution, and quality acceptance of analysis deliverables. The position requires demonstrated experience in managing complex analytical workflows across multiple programs to generate high-quality analysis results in a GxP compliant programming environment using a broad range of RWD sources. Director level: Shapes TA-level analysis delivery strategy, drives cross-program prioritization, influences development and implementation of standards and analytical capabilities across CDS-RWE, in addition to execution oversight. Key Responsibilities: • Responsible for working with the CDS-RWE TA Head to track, prioritize and manage the execution of analysis deliverables across the TA portfolio • Partner with the CDS-RWE TA Head on data strategy and advanced analytical tools and methods to enable the TA portfolio • Responsible for vendor performance management and escalation of risks impacting the TA portfolio • Responsible for the vendor oversight plans, performance and quality checks, for programming, analysis and other deliverables per the vendor oversight process • Own end-to-end oversight of analysis deliverables, ensuring timely, high-quality completion aligned to TA priorities, with proactive risk identification and mitigation • Partner with the CDS-RWE scientific leads to monitor translation of observational research protocols and analysis requirements into analysis specifications and deliverables by vendors or service providers • Monitor and review the quality of programming and analysis deliverables e.g., specifications, programs, cohorts, feasibility results, analysis results, publications, abstracts, and other outputs • Ensure locking or archiving of programming and analysis deliverables and outputs, as appropriate • Monitor utilization and coordinate assignment of analyses to vendors or service providers • Serve as an escalation point to resolve quality, scope and timeliness issues with vendors and service providers • Maintain regular communication with vendors and service providers to deliver on agreed upon prioritie